◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
康泰医学 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
+Revenue 480.0M 747.0M 712.0M 909.0M 1.4B
Revenue Growth % -35.7% 4.9% -21.7% -35.1% --
Total Revenue 480.0M 747.0M 712.0M 909.0M 1.4B
Cost Of Revenue 243.0M 317.0M 374.0M 463.0M 585.0M
+Gross Profit 237.0M 430.0M 338.0M 446.0M 816.0M
Gross Margin % 49.4% 57.6% 47.5% 49.1% 58.2%
Total Operating Cost 579.0M 607.0M 560.0M 521.0M 724.0M
Selling Expenses 88.5M 118.0M 90.2M 66.1M 61.2M
Admin Expenses 40.8M 41.8M 34.4M 32.8M 33.6M
Rd Expenses 105.0M 111.0M 93.3M 66.1M 48.7M
Finance Expenses -18.3M -30.9M -50.3M -124.0M -17.0M
+Operating Income -67.6M 187.0M 219.0M 406.0M 715.0M
Operating Margin % -14.1% 25.0% 30.8% 44.7% 51.0%
Non Operating Income 1.6M 476,300 483,400 2.6M 2.1M
Non Operating Expenses 8.0M 1.1M 364,700 381,800 1.2M
Investment Income 22.5M 11.5M 8.0M 1.6M 167,800
Fair Value Change Income 1.6M 2.0M 46.6M -- --
Asset Disposal Income 166,200 -67,800 -259,800 -43,700 -1,200
Asset Impairment Loss 109.0M 39.1M 5.8M 10.7M 3.8M
Other Income 7.3M 33.3M 12.4M 16.4M 37.3M
Income Before Tax -73.9M 186.0M 219.0M 408.0M 715.0M
Income Tax 4.0M 20.4M 23.2M 55.6M 102.0M
+Net Income -77.9M 166.0M 196.0M 352.0M 613.0M
Net Margin % -16.2% 22.2% 27.5% 38.7% 43.8%
Net Income Attributable -77.9M 166.0M 196.0M 352.0M 613.0M
Eps Basic -0.19 0.41 0.49 0.88 1.64
Eps Diluted -0.17 0.40 0.48 -- --
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash And Equivalents 684.0M 471.0M 1.4B 624.0M 814.0M
Trading Financial Assets 172.0M 652.0M 46.6M -- --
Accounts Receivable 46.0M 39.9M 161.0M 66.2M 102.0M
Notes And Accounts Receivable 46.0M 39.9M 161.0M 66.2M 102.0M
Prepayments 6.2M 6.8M 26.6M 9.3M 11.6M
Inventory 272.0M 463.0M 430.0M 419.0M 284.0M
Total Current Assets 1.9B 2.5B 2.6B 1.4B 1.3B
Fixed Assets -- 261.0M 268.0M 171.0M 147.0M
Fixed Assets Total 259.0M 261.0M 268.0M 171.0M 147.0M
Construction In Progress -- 24.5M 1.3M 51.2M 3.9M
Construction In Progress Total 72.8M 24.5M 1.3M 51.2M 3.9M
Intangible Assets 52.1M 54.7M 57.5M 33.6M 13.1M
Long Term Deferred Expenses 70,500 -- -- -- --
Total Non Current Assets 804.0M 730.0M 1.2B 1.4B 831.0M
Total Assets 2.7B 3.2B 3.7B 2.8B 2.1B
Short Term Borrowings 60.0M 347.0M 903.0M 800.0M 268.0M
Accounts Payable 18.4M 17.8M 54.3M 47.6M 93.4M
Advance Receipts -- -- -- -- --
Contract Liabilities 32.0M 40.0M 76.6M 45.6M 38.6M
Total Current Liabilities 135.0M 460.0M 1.1B 956.0M 515.0M
Total Non Current Liabilities 733.0M 707.0M 692.0M 13.3M 14.1M
Total Liabilities 868.0M 1.2B 1.8B 969.0M 529.0M
Paid In Capital 402.0M 402.0M 402.0M 402.0M 402.0M
Capital Reserve 352.0M 345.0M 345.0M 345.0M 345.0M
Surplus Reserve 174.0M 174.0M 158.0M 138.0M 104.0M
Retained Earnings 892.0M 1.1B 992.0M 936.0M 718.0M
Equity Attributable 1.9B 2.0B 1.9B 1.8B 1.6B
Total Equity 1.9B 2.0B 1.9B 1.8B 1.6B
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash From Sales 492.0M 899.0M 694.0M 934.0M 1.4B
Tax Refunds Received 6.3M 48.6M 38.1M 71.5M 71.8M
Total Operating Cash Inflow 526.0M 989.0M 797.0M 1.0B 1.5B
Cash Paid For Goods 120.0M 382.0M 370.0M 629.0M 669.0M
Cash Paid To Employees 185.0M 208.0M 172.0M 171.0M 160.0M
Taxes Paid 47.0M 83.5M 48.0M 132.0M 40.2M
Total Operating Cash Outflow 464.0M 808.0M 693.0M 1.0B 942.0M
Operating Cash Flow 62.3M 181.0M 104.0M 4.6M 598.0M
Total Investing Cash Inflow 5.4B 168.0M 22.3M 55.2M 3.8M
Total Investing Cash Outflow 5.5B 891.0M 136.0M 106.0M 319.0M
Investing Cash Flow -106.0M -723.0M -114.0M -51.1M -315.0M
Cash From Borrowings 90.0M 633.0M 875.0M 915.0M 263.0M
Dividends And Interest Paid 128.0M 68.7M 124.0M 102.0M 1.9M
Debt Repayments 377.0M 1.2B 787.0M 312.0M 18.5M
Total Financing Cash Inflow 763.0M 1.1B 1.7B 915.0M 700.0M
Total Financing Cash Outflow 507.0M 1.5B 964.0M 1.1B 322.0M
Financing Cash Flow 256.0M -383.0M 781.0M -166.0M 379.0M
Net Change In Cash 217.0M -920.0M 789.0M -215.0M 651.0M
Ending Cash Balance 684.0M 467.0M 1.4B 599.0M 813.0M
Capex 54.5M 30.7M 81.4M 106.0M 88.7M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...